Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

van Oers, MHJ;Hagenbeek, A.;Van Glabbeke, Martine;Teodorovic, I.
(2002) Annals of Hematology — Vol. 81, n° 10, p. 553-557 (2002)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 141.28 KB
No access

Details

Authors
  • van Oers, MHJ
    Author
  • Hagenbeek, A.
    Author
  • Van Glabbeke, MartineUCLouvain
    Author
  • Teodorovic, I.
    Author
Affiliations

Citations

  • APA
  • Chicago
  • FWB

van Oers, M., Hagenbeek, A., Van Glabbeke, M., & Teodorovic, I. (2002). Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin’s lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study. Annals of Hematology, 81(10), 553-557. https://doi.org/10.1007/s00277-002-0548-2 (Original work published 2002)